Re-Engineered Discharge for Diabetes Care Transitions
Recruiting · NCT06869057 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Massachusetts, Worcester
View the official record on ClinicalTrials.gov →Interventions studied
REDDCAT2 Post-Discharge NavigationTreatment as Usual (TAU)
What this trial is about
The goal of this project is to test a novel bedside SDOH screening intervention coupled with post-discharge navigation for hospitalized patients with a diabetes diagnosis to reduce unmet social needs, compared to usual care.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- adult aged 18 years or older
- diagnosed with type 2 diabetes
- hospitalized at Univ of Massachusetts-affiliated hospital
- endorsed at least 1 unmet social need via screening survey
Exclusion criteria
- pregnancy
- discharge to short or long-term nursing facility or hospital
- medical contraindication
- cognitive impairment
- unable to provide informed consent
Where it is running
1 location listed across 1 US state.
- UMASS Memorial Healthcare System - Worcester, Massachusetts, United States